Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Chromosomal microarray analysis (CMA) by array‐based comparative genomic hybridization (CGH) is a new clinical test for the detection of well‐characterized genomic disorders caused by chromosomal deletions and duplications that result in gene copy number variation (CNV). This powerful assay detects an abnormality in approximately 7–9% of patients with various clinical phenotypes, including mental retardation. We report here on the results found in a 6‐year‐old girl with mildly dysmorphic facies, obesity, and marked developmental delay. CMA was requested and showed a heterozygous loss in copy number with clones derived from the genomic region cytogenetically defined as Xq27.3–Xq28. This loss was not cytogenetically visible but was seen on FISH analysis with clones from the region. Further studies confirmed a loss of one copy each of the FMR1, FMR2, and IDS genes (which are mutated in Fragile X syndrome, FRAXE syndrome, and Hunter syndrome, respectively). Skewed X‐inactivation has been previously reported in girls with deletions in this region and can lead to a combined Fragile X/Hunter syndrome phenotype in affected females. X‐inactivation and iduronate 2‐sulfatase (IDS) enzyme activity were therefore examined. X‐inactivation was found to be random in the child's peripheral leukocytes, and IDS enzyme activity was approximately half of the normal value. This case demonstrates the utility of CMA both for detecting a submicroscopic chromosomal deletion and for suggesting further testing that could possibly lead to therapeutic options for patients with developmental delay. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Self-citationFu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080 · cited 1×
“The FMR1 gene is the gene responsible for Fragile X syndrome (OMIM þ309550) [Fu et al., 1991; Kremer et al., 1991; Oberle et al., 1991; Verkerk et al., 1991; Yu et al., 1991].”
BackgroundSelf-citationInstability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
The DNA sequence of the human X chromosome
Ross, M. T., Grafham, D. V., Coffey, A. J., Scherer, S., McLay, K., Muzny, D., Platzer, M., Howell, G. R., Burrows, C., Bird, C. P., et al. (2005) · Nature · doi:10.1038/nature03440 · Cited by 1,129 · cited 1×
“These clones have both been sequenced (accession numbers AL358174 and AC136957, respectively) so the estimated size of the deletion based on the CMA and FISH data is less than 4.4 megabases [Lander et al., 2001; Kent et al., 2002; Ross et al., 2005].”
BackgroundInfluentialSelf-citationLaporte, J., Hu, L. J., Kretz, C., Mandel, J.-L., Kioschis, P., Coy, J. F., Klauck, S. M., Poustka, A., & Dahl, N. (1996) · Nature Genetics · doi:10.1038/ng0696-175 · Cited by 639 · cited 2×
“CMA is a new clinical diagnostic tool that can detect hundreds of different chromosomal deletions and duplications, including submicroscopic lesions that cannot be identified with routine chromosome analysis [Cheung et al., 2005; Lu et al., 2007].”
BackgroundInfluentialA PEDIGREE OF MENTAL DEFECT SHOWING SEX-LINKAGE
Martin, J. P., & Bell, J. (1943) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.6.3-4.154 · Cited by 481
Cited by
Epigenetic principles and mechanisms underlying nervous system functions in health and disease
MEHLER, M. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.10.001 · Cited by 291
Protein interactome reveals converging molecular pathways among autism disorders
Sakai, Y., Shaw, C. A., Dawson, B. C., Dugas, D. V., Al-Mohtaseb, Z., Hill, D. E., & Zoghbi, H. Y. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002166 · Cited by 226
“Using the custom 4×44K chips, we performed DNA digestion, labeling, and hybridization as previously described (53, 54).”
MethodSelf-citation22q13.3 deletion syndrome: clinical and molecular analysis using array CGH
Dhar, S. U., del Gaudio, D., German, J. R., Peters, S. U., Ou, Z., Bader, P. I., Berg, J. S., Blazo, M., Brown, C. W., Graham, B. H., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33253 · Cited by 138
“The procedures for DNA digestion, labeling, and hybridization were performed according to the manufacturer’s instructions with some modifications [Probst et al., 2007].”
MethodSelf-citationFragile sites, chromosomal lesions, tandem repeats, and disease
Mirceta, M., Shum, N., Schmidt, M. H. M., & Pearson, C. E. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.985975 · Cited by 30
“(CGG)31–61; premutation • Deletions, missense mutations and duplications of AFF2 gene linked to ID and autism: (Gecz et al., 1996; Moore et al., 1999; Probst et al., 2007; Whibley et al., 2010; Cavani et al., 2011; Stettner et al., 2011; Mondal et al., 2012)”
Background
Metadata
- Authors
- Probst, F. J., Roeder, E. R., Enciso, V. B., Ou, Z., Cooper, M. L., Eng, P., Li, J., Gu, Y., Stratton, R. F., Chinault, A. C., Shaw, C. A., Sutton, V. R., Cheung, S. W., & Nelson, D. L.
- Venue
- American Journal of Medical Genetics Part A
- Publisher
- Wiley
- Published
- 2007-05-15
- Volume
- 143A
- Issue
- 12
- Pages
- 1358-1365
- ISSN
- 1552-4825 (ISSN-L)
- 1552-4833
- OpenAlex
- W2090572207
- Cited by
- 60
- References
- 6
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.